CID 1864797

573945-36-5

Structural Information

Molecular Formula
C24H21N7OS2
SMILES
CCN1C(=NN=C1SCC(=O)NC2=CC=C(C=C2)C3=NC4=C(S3)C=C(C=C4)C)C5=NC=CN=C5
InChI
InChI=1S/C24H21N7OS2/c1-3-31-22(19-13-25-10-11-26-19)29-30-24(31)33-14-21(32)27-17-7-5-16(6-8-17)23-28-18-9-4-15(2)12-20(18)34-23/h4-13H,3,14H2,1-2H3,(H,27,32)
InChIKey
BHWLXWLWPJRILH-UHFFFAOYSA-N
Compound name
2-[(4-ethyl-5-pyrazin-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

487.1249 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 488.132176 209.4
[M+Na]+ 510.114118 221.9
[M-H]- 486.117624 217.8
[M+NH4]+ 505.158723 215.0
[M+K]+ 526.088058 212.3
[M+H-H2O]+ 470.122160 200.8
[M+HCOO]- 532.123101 219.4
[M+CH3COO]- 546.138751 217.7
[M+Na-2H]- 508.099566 207.9
[M]+ 487.12435142 216.6
[M]- 487.12544858 216.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.